Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis

被引：0
|
作者：
Yuko Kanbayashi
Yuichi Ishizuka
Mayumi Shimizu
Shohei Sawa
Katsushige Yabe
Mayako Uchida
机构：
[1] Osaka Medical and Pharmaceutical University,Department of Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy
[2] Seirei Hamamatsu General Hospital,Department of Pharmacy
[3] Doshisha Women’s College of Liberal Arts,Department of Education and Research Center for Pharmacy Practice
来源：
Supportive Care in Cancer | 2022年 / 30卷
关键词：
OIC; Laxatives; Taxane; Naldemedine; BMI; Cancer pain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5831 / 5836
页数：5
相关论文
共 50 条
  • [1] Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis
    Kanbayashi, Yuko
    Ishizuka, Yuichi
    Shimizu, Mayumi
    Sawa, Shohei
    Yabe, Katsushige
    Uchida, Mayako
    SUPPORTIVE CARE IN CANCER, 2022, 30 (07) : 5831 - 5836
  • [2] Factors affecting the effect of naldemedine for opioid-induced constipation: a single-institution, retrospective analysis
    Kanbayashi, Y.
    Amaya, F.
    Ueno, H.
    Tabuchi, Y.
    Ishikawa, T.
    Takayama, K.
    Taguchi, T.
    PHARMAZIE, 2021, 76 (04): : 175 - 178
  • [3] Opioid-Induced Constipation in Advanced Cancer Patients
    ALMouaalamy, Nabil
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [4] METHYLNALTREXONE FOR OPIOID-INDUCED CONSTIPATION IN PATIENTS WITH ADVANCED CANCER: RESULTS OF A RETROSPECTIVE STUDY
    Costanzo, R.
    Russo, G.
    Piccirillo, M. C.
    Morabito, A.
    Esposito, G.
    Di Maio, M.
    Forte, C.
    Perrone, F.
    Cuomo, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 399 - 399
  • [5] Methylnaltrexone treatment of opioid-induced constipation in cancer patients
    Karver, S. B.
    Slatkin, N. E.
    Thomas, J.
    Israel, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] A retrospective study of the efficacy and safety of naldemedine for opioid-induced constipation in thoracic cancer patients
    Imai, Hisao
    Fujita, Yukiyoshi
    Hiruta, Eriko
    Masuno, Takashi
    Yamazaki, Shigeki
    Tanaka, Hajime
    Kamiya, Teruhiko
    Sandoh, Mitsuru
    Takei, Satoshi
    Arai, Kazuya
    Nishiba, Hiromi
    Mogi, Junnosuke
    Kaira, Kyoichi
    Minato, Koichi
    THORACIC CANCER, 2022, 13 (16) : 2301 - 2308
  • [7] Efficacy and safety of naldemedine for opioid-induced constipation in older patients with cancer: a retrospective study
    Imai, Hisao
    Fujita, Yukiyoshi
    Hiruta, Eriko
    Masuno, Takashi
    Yamazaki, Shigeki
    Tanaka, Hajime
    Kamiya, Teruhiko
    Sandoh, Mitsuru
    Takei, Satoshi
    Arai, Kazuya
    Nishiba, Hiromi
    Mogi, Junnosuke
    Koizuka, Shiro
    Saito, Taeko
    Obayashi, Kyoko
    Kaira, Kyoichi
    Minato, Koichi
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (05) : 571 - 577
  • [8] Lubiprostone for Treatment of Opioid-induced Constipation: Analysis of Influencing Factors
    Losch-Beridon, Taryn
    Lichtlen, Peter
    Wang, Martin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S533 - S533
  • [9] Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis
    Kanbayashi, Yuko
    Shimizu, Mayumi
    Ishizuka, Yuichi
    Sawa, Shohei
    Yabe, Katsushige
    Uchida, Mayako
    PLOS ONE, 2022, 17 (12):
  • [10] Management of Opioid-Induced Constipation in Cancer Patients Focus on Methylnaltrexone
    Gatti, Antonio
    Sabato, Alessandro Fabrizio
    CLINICAL DRUG INVESTIGATION, 2012, 32 (05) : 293 - 301
12345